SALL3
Basic information
Region (hg38): 18:78979818-79002677
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SALL3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 114 | 14 | 128 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 114 | 17 | 1 |
Variants in SALL3
This is a list of pathogenic ClinVar variants found in the SALL3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
18-78980319-C-G | not specified | Uncertain significance (Dec 13, 2023) | ||
18-78980330-T-C | not specified | Likely benign (Apr 07, 2023) | ||
18-78980335-C-T | not specified | Uncertain significance (Apr 25, 2023) | ||
18-78992096-G-C | not specified | Likely benign (May 25, 2022) | ||
18-78992109-G-C | not specified | Uncertain significance (May 06, 2024) | ||
18-78992145-G-T | not specified | Uncertain significance (Jul 12, 2023) | ||
18-78992160-T-C | not specified | Uncertain significance (Aug 17, 2022) | ||
18-78992167-A-C | not specified | Uncertain significance (Mar 07, 2024) | ||
18-78992181-G-A | not specified | Likely benign (Apr 01, 2024) | ||
18-78992190-C-A | not specified | Uncertain significance (Oct 25, 2023) | ||
18-78992208-T-A | not specified | Uncertain significance (Jun 18, 2024) | ||
18-78992212-C-G | not specified | Uncertain significance (Feb 10, 2022) | ||
18-78992235-G-A | not specified | Uncertain significance (May 09, 2023) | ||
18-78992235-G-T | not specified | Uncertain significance (Jul 12, 2023) | ||
18-78992265-G-A | not specified | Uncertain significance (Aug 23, 2021) | ||
18-78992321-G-C | not specified | Uncertain significance (Jan 23, 2024) | ||
18-78992436-C-G | not specified | Uncertain significance (Nov 29, 2021) | ||
18-78992443-C-T | not specified | Uncertain significance (Dec 19, 2022) | ||
18-78992451-C-T | not specified | Uncertain significance (May 15, 2023) | ||
18-78992460-C-G | not specified | Likely benign (Aug 11, 2022) | ||
18-78992464-C-T | not specified | Uncertain significance (Jun 24, 2022) | ||
18-78992521-C-T | not specified | Uncertain significance (Dec 01, 2022) | ||
18-78992538-C-G | not specified | Uncertain significance (Oct 05, 2021) | ||
18-78992542-G-A | not specified | Uncertain significance (Jul 27, 2022) | ||
18-78992546-G-A | Likely benign (Oct 09, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SALL3 | protein_coding | protein_coding | ENST00000537592 | 3 | 22403 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.403 | 0.597 | 125670 | 0 | 75 | 125745 | 0.000298 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.310 | 756 | 780 | 0.969 | 0.0000576 | 8239 |
Missense in Polyphen | 216 | 300.73 | 0.71825 | 2843 | ||
Synonymous | -2.66 | 458 | 391 | 1.17 | 0.0000356 | 2734 |
Loss of Function | 3.74 | 6 | 27.0 | 0.223 | 0.00000125 | 324 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000809 | 0.000750 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000168 | 0.000163 |
Finnish | 0.000167 | 0.000139 |
European (Non-Finnish) | 0.000278 | 0.000255 |
Middle Eastern | 0.000168 | 0.000163 |
South Asian | 0.000686 | 0.000686 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Probable transcription factor.;
Recessive Scores
- pRec
- 0.121
Haploinsufficiency Scores
- pHI
- 0.534
- hipred
- Y
- hipred_score
- 0.806
- ghis
- 0.500
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.307
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sall3
- Phenotype
- craniofacial phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; skeleton phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II;olfactory bulb interneuron development;forelimb morphogenesis;hindlimb morphogenesis;negative regulation of smoothened signaling pathway
- Cellular component
- nucleus
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding